Medicare Enrolled
Dr. Andrew Lipman, M.D.
Medical Oncology · Naples, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lipman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lipman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lipman
Dr. Andrew Lipman is a medical oncology specialist in Naples, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lipman performed 436,219 Medicare services across 7,969 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lipman received a total of $41,107 from 90 pharmaceutical and/or device companies across 763 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lipman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in FL
$41,107 industry payments
Medicare Practice Summary
Medicare Utilization ↗436,219
Medicare services
Top 2% in FL for medical oncology
7,969
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~21,811 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
106,080 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 47,000 | $43 | $137 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
37,980 | $0 | $2 |
| Nivolumab injection (Opdivo) | 34,340 | $24 | $72 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
31,245 | $0 | $4 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
29,160 | $38 | $110 |
| Anti-nausea injection (aprepitant) | 26,780 | $1 | $5 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
21,732 | $0 | $12 |
| Denosumab injection (Prolia/Xgeva) | 15,840 | $18 | $51 |
| Paclitaxel chemotherapy injection | 11,991 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
8,430 | $6 | $23 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
6,333 | $0 | $3 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
5,886 | $36 | $108 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
5,483 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
5,112 | $8 | $9 |
| Injection, docetaxel, 1 mg | 4,695 | $0 | $7 |
| Eflapegrastim injection, 0.1 mg An injection of eflapegrastim-xnst administered at a dose of 0.1 mg. |
4,620 | $27 | $116 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
4,162 | $23 | $185 |
| Bortezomib injection, 0.1 mg Administration of a 0.1 mg dose of bortezomib medication via injection. |
3,628 | $4 | $113 |
| Anti-nausea injection (Aloxi/palonosetron) | 3,200 | $1 | $28 |
| Iron infusion (Monoferric) | 2,700 | $16 | $57 |
| Anti-nausea injection (ondansetron/Zofran) | 2,468 | $0 | $9 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,387 | $99 | $339 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,356 | $11 | $69 |
| Injection, leucovorin calcium, per 50 mg | 1,226 | $3 | $12 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
1,193 | $12 | $61 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
1,190 | $103 | $378 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
823 | $2 | $7 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
565 | $1 | $6 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 504 | $3 | $205 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
485 | $23 | $84 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
430 | $2 | $7 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
426 | $50 | $189 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
403 | $67 | $239 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
401 | $58 | $205 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
400 | $1 | $3 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
391 | $10 | $42 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
388 | $2 | $41 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
379 | $18 | $59 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
372 | $2 | $13 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
346 | $26 | $156 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
301 | $23 | $79 |
| Cyclophosphamide, 100 mg | 297 | $16 | $79 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
291 | $16 | $56 |
| Injection, potassium chloride, per 2 meq | 290 | $0 | $4 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
267 | $144 | $474 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
263 | $52 | $178 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
259 | $7 | $69 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 183 | $135 | $562 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
168 | $1 | $2 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
161 | $29 | $156 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
149 | $26 | $89 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
141 | $45 | $170 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
115 | $123 | $453 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
113 | $138 | $637 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
108 | $1 | $7 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
101 | $16 | $56 |
| Intravenous chemotherapy injection Chemotherapy medication is administered directly into a vein using a push technique. This method involves injecting the drug through a needle or catheter already placed in the vein. |
92 | $80 | $303 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
88 | $3 | $11 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
85 | $2 | $8 |
| New patient office visit, complex (60-74 min) | 81 | $177 | $585 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
69 | $69 | $277 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
34 | $4 | $10 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
19 | $5 | $20 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $80 | $298 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
27.1% high complexity
69.4% medium
3.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$41,107
Total received (2018-2024)
Avg $5,872/year across 7 years
Top 15% in FL for medical oncology
90
Companies
763
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$14,771 (35.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13,428 (32.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,909 (31.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,169
2023
$8,821
2022
$3,435
2021
$3,518
2020
$3,565
2019
$17,035
2018
$1,564
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Kyowa Kirin, Inc.
$10,750
AstraZeneca Pharmaceuticals LP
$4,795
Mylan Institutional Inc.
$3,940
AMAG Pharmaceuticals, Inc.
$3,849
Karyopharm Therapeutics Inc.
$2,288
BeiGene USA, Inc.
$1,976
E.R. Squibb & Sons, L.L.C.
$1,054
Novartis Pharmaceuticals Corporation
$1,014
PFIZER INC.
$873
Janssen Biotech, Inc.
$860
Celgene Corporation
$765
Merck Sharp & Dohme LLC
$756
Merck Sharp & Dohme Corporation
$573
Amgen Inc.
$498
Astellas Pharma US Inc
$486
Incyte Corporation
$462
GENZYME CORPORATION
$442
Genentech USA, Inc.
$441
Seagen Inc.
$426
GlaxoSmithKline, LLC.
$317
Takeda Pharmaceuticals U.S.A., Inc.
$315
Gilead Sciences, Inc.
$305
Bayer HealthCare Pharmaceuticals Inc.
$252
Lilly USA, LLC
$244
ARRAY BIOPHARMA INC
$225
Regeneron Healthcare Solutions, Inc.
$157
Daiichi Sankyo Inc.
$157
Myriad Genetic Laboratories, Inc.
$139
Bayer Healthcare Pharmaceuticals Inc.
$132
ABBVIE INC.
$128
NanoString Technologies, Inc.
$107
Dendreon Pharmaceuticals LLC
$107
EMD Serono, Inc.
$101
Kite Pharma, Inc.
$91
TerSera Therapeutics LLC
$85
Alexion Pharmaceuticals, Inc.
$80
Pharmacyclics LLC, An AbbVie Company
$72
Octapharma USA, Inc.
$70
ADC Therapeutics America, Inc.
$69
Pharmacosmos Therapeutics Inc.
$65
Rigel Pharmaceuticals, Inc.
$63
SOBI, INC
$63
Blueprint Medicines Corporation
$62
MorphoSys, US Inc.
$60
Sun Pharmaceutical Industries Inc.
$59
Agios Pharmaceuticals, Inc.
$58
Puma Biotechnology, Inc.
$56
Ipsen Biopharmaceuticals, Inc
$56
Teva Pharmaceuticals USA, Inc.
$55
Eisai Inc.
$55
AbbVie Inc.
$50
EISAI INC.
$50
JAZZ PHARMACEUTICALS INC.
$44
Genmab U.S., Inc.
$44
Acrotech Biopharma LLC
$41
Deciphera Pharmaceuticals Inc.
$40
Mirati Therapeutics, Inc.
$38
CTI BioPharma Corp.
$37
Jazz Pharmaceuticals Inc.
$37
PharmaEssentia USA Corporation
$36
Sumitomo Pharma America, Inc.
$36
Heron Therapeutics, Inc.
$35
PUMA BIOTECHNOLOGY, INC.
$32
GE HEALTHCARE
$32
Sirtex Medical Inc
$32
Alnylam Pharmaceuticals Inc.
$30
Iovance Biotherapeutics, Inc.
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
SpringWorks Therapeutics, Inc.
$28
Sysmex Inostics Inc
$26
SERVIER PHARMACEUTICALS LLC
$24
Tempus AI, Inc
$23
Exelixis Inc.
$23
Taiho Oncology, Inc.
$20
Array BioPharma Inc.
$19
Aveo Pharmaceuticals, Inc.
$19
ImmunoGen, Inc.
$19
Seattle Genetics, Inc.
$19
Acceleron Pharma, Inc.
$18
TG THERAPEUTICS, INC.
$18
AVEO Pharmaceuticals, Inc.
$17
Aurobindo Pharma USA, Inc.
$15
Helsinn Therapeutics (U.S.), Inc.
$14
Pharmacyclics LLC, an AbbVie Company
$14
TAIHO ONCOLOGY, INC.
$14
INSYS Therapeutics Inc
$13
Myovant Sciences Inc.
$13
Clovis Oncology, Inc.
$12
Veracyte, Inc.
$12
Secura Bio, Inc.
$10
Top 3 companies account for 47.4% of total payments
Associated products mentioned in payments ›
ADCETRIS · ADVATE · ANDEXXA · AYVAKIT · Abraxane · Alecensa · Amtagvi · Avastin · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CALQUENCE · CARVYKTI · CERDELGA · CEREZYME · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · ELAHERE · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · ERLEADA · EVENITY · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FRUZAQLA · Fabhalta · Farydak · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · INVOKAMET · JADENU · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Ogivri · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RYBREVANT · RYDAPT · Reblozyl · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SYNDROS · Stivarga · TABRECTA · TASIGNA · TECVAYLI · TEPMETKO · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VONVENDI · VOTRIENT · VPRIV · Venclexta · Vonjo · Vyloy · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XGEVA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYKADIA · ZYNYZ · ZYTIGA · Zevalin · Zoladex · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (36%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Equivalent to $9 per 100 Medicare services performed
Geographic Context
Medical oncologists within 10 mi
14
Per 100K population
3.6
County median income
$86,173
Nearest hospital
PHYSICIANS REGIONAL MEDICAL CENTER - PINE RIDGE
5.8 mi
5.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lipman is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), with mixed engagement industry engagement in the top 15% of FL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lipman experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Lipman performed 106,080 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lipman receive payments from pharmaceutical companies?
Yes. Dr. Lipman received a total of $41,107 from 90 companies across 763 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lipman's costs compare to other medical oncologists in Naples?
Dr. Lipman's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lipman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Naples
Browse medical oncologists in Naples ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
Kyowa Kirin, Inc. Payments to Doctors
See all physicians who received payments from Kyowa Kirin, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Mylan Institutional Inc. Payments to Doctors
See all physicians who received payments from Mylan Institutional Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology